Nephrology

Satellite Healthcare Joins Other Non-Profit Partners to Open First Dialysis Center in Hawai‘i Focused on Higher-Risk Patients

Retrieved on: 
Monday, September 26, 2022

The center will provide dialysis to patients who live with end-stage renal disease in addition to other health conditions that contribute to their vulnerable health status.

Key Points: 
  • The center will provide dialysis to patients who live with end-stage renal disease in addition to other health conditions that contribute to their vulnerable health status.
  • The center will provide both in-center dialysis and home dialysis training for patients who choose to dialyze at home, a treatment known for faster recovery times and superior outcomes.
  • The center hosted a blessing ceremony this morning where partners from Satellite Healthcare, Queens, Kuakini, and HMSA marked its opening on the Kuakini Health System campus.
  • Through its affiliated services, Satellite WellBound, Satellite Dialysis, and Satellite Research, Satellite Healthcare provides unparalleled kidney care services addressing patient wellness education, chronic kidney care management, and personalized clinical services.

EQS-News: How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication

Retrieved on: 
Friday, September 23, 2022

Most people are surprised to learn that chronic kidney disease (CKD) is the fastest growing, non-communicable disease in the United States.

Key Points: 
  • Most people are surprised to learn that chronic kidney disease (CKD) is the fastest growing, non-communicable disease in the United States.
  • In fact, each year, more people die from this silent killer than from breast or prostate cancer.
  • Hyperphosphatemia (elevated phosphorus levels in the blood) is a common complication of CKD affecting over 80% of dialysis patients.
  • UNI-494 is a patent-protected new chemical entity in late preclinical development for the treatment of acute kidney injury.

Worldwide Active Pharmaceutical Ingredients Industry to 2029 - Featuring Pfizer, Sanofi, AbbVie and Cipla Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 21, 2022

In 2021, the synthetic API segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period.

Key Points: 
  • In 2021, the synthetic API segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period.
  • This can be attributed to the increase in accessibility of raw materials along with relaxed protocols for the production of these molecules worldwide.
  • In 2021, the captive APIs segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
  • This is attributed to rising accessibility to raw materials and widespread investments by major manufacturers for developing high-end industrialized facilities worldwide.

Despite Amplified Use of SGLT2 Inhibitors for Glomerular Diseases, EU and US Nephrologists Express a Continued Strong Desire for New Treatment Options for FSGS Patients, Spherix Reports

Retrieved on: 
Wednesday, September 21, 2022

EXTON, PA., Sept. 21, 2022 /PRNewswire/ -- Focal segmental glomerulosclerosis (FSGS) is one of the leading causes of nephrotic syndrome across the world and is considered the most common glomerular cause of end-stage renal disease (ESRD).1 Spherix has been tracking the evolution of the FSGS market since 2018 to keep a pulse on how nephrologists are treating patients and the perceived potential for products as they make their way through development.

Key Points: 
  • Over the past few months, Spherix has released two reports revealing insights from both US-based and EU5-based nephrologists as a part of its Market Dynamix: Focal Segmental Glomerulosclerosis (FSGS) research services.
  • Of note, Spherix experts found that while most FSGS patients are still confirmed via kidney biopsies, nephrologists are becoming increasingly likely to use genetic testing for diagnosis.
  • In fact, reported use of SGLT2 inhibitors in primary FSGS patients more than doubled year-over-year in both regions captured in these studies, with expectations for continued growth.
  • To gauge pipeline product potential, Spherix assessed awareness, familiarity, desire to have approved, likelihood to prescribe, and estimated patient candidacy for the following assets:

VHA Awards Dialysis Electronic Medical Record Software and Maintenance Electronic Health Record Contract to DSS, Inc

Retrieved on: 
Tuesday, September 20, 2022

JUNO BEACH, Fla., Sept. 20, 2022 /PRNewswire-PRWeb/ -- Document Storage Systems, Inc. (DSS, Inc.), a leading provider of health information technology (HIT) solutions for federal, private, and public health care organizations, today announced a contract award from the Veterans Health Administration (VHA) for the Dialysis Electronic Medical Record Software and Maintenance Electronic Health Record (EHR).

Key Points: 
  • JUNO BEACH, Fla., Sept. 20, 2022 /PRNewswire-PRWeb/ -- Document Storage Systems, Inc. ( DSS, Inc. ), a leading provider of health information technology (HIT) solutions for federal, private, and public health care organizations, today announced a contract award from the Veterans Health Administration (VHA) for the Dialysis Electronic Medical Record Software and Maintenance Electronic Health Record (EHR).
  • "This renewed contract will help the VHA to more easily capture and report dialysis data.
  • These modules combine to integrate real-time data with workflow automation, helping VHA caregivers more efficiently manage renal care and dialysis patient treatment.
  • This new contract is expected to be utilized by the remaining 31 VA dialysis outpatient facilities with the potential to impact the dialysis inpatient facilities as well.

American Heart Association Report Supports Dialyze Direct’s Cutting-Edge Dialysis Modality

Retrieved on: 
Tuesday, September 20, 2022

Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), heralds the American Heart Associations (AHA) recent endorsement of home dialysis therapies, including the more frequent hemodialysis (MFD) model of care, in its report, Cardiovascular Effects of Home Dialysis Therapies.

Key Points: 
  • Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), heralds the American Heart Associations (AHA) recent endorsement of home dialysis therapies, including the more frequent hemodialysis (MFD) model of care, in its report, Cardiovascular Effects of Home Dialysis Therapies.
  • As noted in the report, cardiovascular disease is the leading cause of death in patients with ESKD.
  • Just this year, Dialyze Directs medical professionals validated a new application of MFD for the elderly and frail SNF population with ESKD.
  • MFD is at the core of Dialyze Directs patient-centric approach to dialysis treatment when a patient exhibits comorbidities that deem it medically necessary.

Autosomal Dominant Polycystic Kidney Disease Market to Surge at a Significant CAGR of 14.5% by 2032 | DelveInsight

Retrieved on: 
Monday, September 19, 2022

LAS VEGAS, Sept. 19, 2022 /PRNewswire/ -- DelveInsight's ADPKD Market Insights report includes a comprehensive understanding of current treatment practices, ADPKD emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), Japan].

Key Points: 
  • In addition, the approval and entry of new drugs will change the ADPKD market dynamics in the future.
  • As per DelveInsight estimates, the ADPKDmarket size in the 7MM was approximately USD 1,077 million in 2021.
  • Autosomal dominant polycystic kidney disease also called "adult PKD," is the most common inherited kidney disorder characterized by cyst growth in the kidneys, which increases with disease progression and results in renal failure.
  • Implementing these measures early in the disease should slow the progression of kidney (renal) disease and, to some extent, preserve kidney function.

Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer

Retrieved on: 
Monday, September 19, 2022

DUBLIN, Sept. 19, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022.

Key Points: 
  • DUBLIN, Sept. 19, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022.
  • Ms. French will serve on the Executive Committee and succeeds Hugh O'Neill, who departed Mallinckrodt as of September 16, 2022.
  • Ms. French most recently built and led the U.S. Women's Health Commercial team for Organon & Co. following its spin-off from Merck.
  • Siggi Olafsson, President and Chief Executive Officer, said, "I am delighted to welcome Lisa to Mallinckrodt as our new Chief Commercial Officer and a member of our Executive Committee.

Gold Kidney Health Plan Launches in Arizona

Retrieved on: 
Thursday, September 15, 2022

SCOTTSDALE, Ariz., Sept. 15, 2022 /PRNewswire/ -- Gold Kidney of Arizona, Inc., a subsidiary of Gold Kidney Health Plan has contracted with the Centers of Medicare and Medicaid (CMS) and is launching a Medicare Advantage Chronic-Care Special Needs Plan effective January 1, 2023. Gold Kidney of Arizona will offer the same coverage as Medicare with additional benefits, designed for patients with Chronic Kidney Disease that lead to and include Kidney Failure.

Key Points: 
  • Medicare Health Plan in Arizona specifically designed for Medicare beneficiaries living with Diabetes, Heart Failure, Cardiovascular Disease and End Stage Kidney Disease
    SCOTTSDALE, Ariz., Sept. 15, 2022 /PRNewswire/ -- Gold Kidney of Arizona, Inc., a subsidiary of Gold Kidney Health Plan has contracted with the Centers of Medicare and Medicaid (CMS) and is launching a Medicare Advantage Chronic-Care Special Needs Plan effective January 1, 2023.
  • Gold Kidney of Arizona will offer the same coverage as Medicare with additional benefits, designed for patients with Chronic Kidney Disease that lead to and include Kidney Failure.
  • Gold Kidney of Arizona will begin enrolling members in its new Medicare Advantage plan beginning October 15, 2022.
  • "We are really pleased to offer the Medicare Health Plan in Arizona Intended for Medicare beneficiaries living with chronic conditions that lead to and include kidney failure," said Dave Firdaus, CEO of Gold Kidney Health Plan.

CapStone Holdings Inc. and Gamers Outreach Bring Gaming to Children's Hospitals in St. Louis

Retrieved on: 
Thursday, September 15, 2022

ST. LOUIS, Sept. 15, 2022 /PRNewswire/ -- CapStone Holdings Inc. ("CapStone Holdings") partnered with Michigan-based non-profit organization Gamers Outreach to gift gaming carts (GO Karts -- portable gaming kiosks) to St. Louis Children's Hospital and SSM Health Cardinal Glennon Children's Hospital. Each hospital received four GO Karts with the intent to offer a form of recreation to kids and young adults in inpatient care.

Key Points: 
  • Eight portable gaming units were donated to St. Louis Children's Hospital and Cardinal
    ST. LOUIS, Sept. 15, 2022 /PRNewswire/ -- CapStone Holdings Inc. ("CapStone Holdings") partnered with Michigan-based non-profit organization Gamers Outreach to gift gaming carts (GO Karts -- portable gaming kiosks) to St. Louis Children's Hospital and SSM Health Cardinal Glennon Children's Hospital.
  • We are so grateful for this donation from CapStone Holdings and Gamers Outreach.
  • Gamers Outreach has since delivered kiosks to more than 360 hospitals worldwide servicing as many as 4 million patients each year.
  • Through equipment and software, Gamers Outreach is helping kids in hospitals gain access to activities and do what kids do best - be themselves.